Pfizer CEO Jeff Kindler has finally thrown out the Exubera baby with the bong water, saying, “We made an important decision regarding Exubera, a product for which we initially had high expectations. Despite our best efforts, Exubera has failed to gain the acceptance of patients and physicians. We have therefore concluded that further investment [...]

[Read more →]